RESUMO
Bacterial extracellular vesicles (BEVs) are proteoliposome nanoparticles that are secreted by both Gram-negative (G-) and Gram-positive (G+) bacteria. BEVs have significant roles in various physiological processes of bacteria, including driving inflammatory responses, regulating bacterial pathogenesis, and promoting bacterial survival in diverse environments. Recently, there has been increasing interest in the use of BEVs as a potential solution to antibiotic resistance. BEVs have shown great promise as a new approach to antibiotics, as well as a drug-delivery tool in antimicrobial strategies. In this review, we provide a summary of recent scientific advances in BEVs and antibiotics, including BEV biogenesis, ability to kill bacteria, potential for delivering antibiotics, and their role in the development of vaccines or as immune adjuvants. We propose that BEVs provide a novel antimicrobial strategy that would be beneficial against the increasing threat of antibiotic resistance.
Assuntos
Anti-Infecciosos , Vesículas Extracelulares , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Bactérias , Sistemas de Liberação de MedicamentosRESUMO
Methicillin-resistant Staphylococcus aureus (MRSA), a notorious bacterium with high drug resistance and easy recurrence after surgery, has posed significant clinical treatment challenges. In the current scarcity of new antibiotics, the identification of adjuvants to existing antibiotics is a promising approach to combat infections caused by multidrug-resistant Gram-positive bacteria. The in vitro synergy test, which included a MIC assay, time-kill curve, antimicrobial susceptibility testing, and live/dead bacteria staining assay, revealed that laurocapram, a widely used chemical transdermal enhancer, could potentiate the antibacterial activity of cephalosporins against MRSA. In vitro, laurocapram combined with cefixime showed an excellent synergistic activity against MRSA (FICI = 0.28 ± 0.00). In addition, the combination of laurocapram and cefixime may inhibited the formation of MRSA biofilm and caused cell membrane damage. Following that, we discovered that combining laurocapram with cefixime could alleviate the symptoms of mice in the MRSA skin infection model and the MRSA pneumonia model. In conclusion, laurocapram is a promising and low-cost antibacterial adjuvant, providing a new strategy for further exploring the use of lower doses of cephalosporins to combat MRSA infection.
Assuntos
Antibacterianos , Cefalosporinas , Staphylococcus aureus Resistente à Meticilina , Testes de Sensibilidade Microbiana , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Cefalosporinas/administração & dosagem , Cefalosporinas/farmacologia , Camundongos , Feminino , Administração Cutânea , Sinergismo Farmacológico , Camundongos Endogâmicos BALB C , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Infecções Cutâneas Estafilocócicas/microbiologia , Infecções Estafilocócicas/tratamento farmacológicoRESUMO
Catalytic oxidation is considered to be the most efficient technology for eliminating benzene from waste gas. The challenge is the reduction of the catalytic reaction temperature for the deep oxidation of benzene. Here, highly efficient RuxCeO2 catalysts were utilized to turn the number of surface oxygen vacancies and Ce-O-Ru bonds via a one-step hydrothermal method, resulting in a preferable low-temperature reducibility for the total oxidation of benzene. The T50 of the Ru0.2CeO2 catalyst for benzene oxidation was 135 °C, which was better than that of pristine CeO2 (239 °C) and 0.2Ru/CeO2 (190 °C). The superior performance of Ru0.2CeO2 was attributed to its large surface area (approximately 114.23 m2·g-1), abundant surface oxygen vacancies, and Ce-O-Ru bonds. The incorporation of Ru into the CeO2 lattice could effectively facilitate the destruction of the CeO bond and the facile release of lattice oxygen, inducing the generation of surface oxygen vacancies. Meanwhile, the bridging action of Ce-O-Ru bonds accelerated electron transfer and lattice oxygen transportation, which had a synergistic effect with surface oxygen vacancies to reduce the reaction temperature. The Ru0.2CeO2 catalyst also exhibited high catalytic stability, water tolerance, and impact resistance in terms of benzene abatement. Using in situ infrared spectroscopy, it was demonstrated that the Ru0.2CeO2 catalyst can effectively enhance the accumulation of maleate species, which are key intermediates for benzene ring opening, thereby enhancing the deep oxidation of benzene.